Rocket Doctor AI Reports First Revenues in Q2, 2025 Following Acquisition
(AIDR) Vancouver, British Columbia, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (formerly Treatment.com AI Inc.). (the “Company”) (CSE: AIDR; OTC: TREIF; FFA: 939) is pleased to anno...
What is the anticipated impact of the first revenue run‑rate on the stock’s valuation relative to peers in the AI health sector?
When will the company provide guidance on future revenue growth and profitability post‑acquisition?
How much revenue did Rocket Doctor AI generate in Q2 and how does it compare to the acquisition's contribution expectations?
20 days ago